Double Medical Technology Inc. (SHE:002901)

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2022	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Jan 1, 2022	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015
Trauma Product	821.09M	572.37M	542.45M	1.13B	980.75M
Trauma Product Growth	43.45%	5.52%	-51.89%	14.97%	-
Spine Product	388.28M	283.67M	472.10M	565.38M	369.20M
Spine Product Growth	36.88%	-39.91%	-16.50%	53.14%	-
Minimally Invasive Surgery Products	362.67M	286.64M	191.60M	149.63M	111.50M
Minimally Invasive Surgery Products Growth	26.52%	49.60%	28.05%	34.20%	-
Joint Products	189.33M	156.32M	58.61M	21.45M	-
Joint Products Growth	21.11%	166.70%	173.25%	-	-
Neurosurgical Products	102.91M	81.48M	46.99M	43.82M	38.13M
Neurosurgical Products Growth	26.29%	73.41%	7.23%	14.93%	-
Dental Products	67.02M	52.26M	24.76M	-	-
Dental Products Growth	28.25%	111.08%	-	-	-
Other Products	161.94M	67.14M	74.05M	60.97M	55.35M
Other Products Growth	141.20%	-9.33%	21.45%	10.16%	-
Surgical Instrument	42.32M	33.23M	23.53M	20.45M	28.55M
Surgical Instrument Growth	27.35%	41.21%	15.06%	-28.36%	-
Total	2.14B	1.53B	1.43B	1.99B	1.58B
Total Growth	39.29%	6.90%	-27.91%	25.63%	-

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2022	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Jan 1, 2022	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015
China	1.92B	1.32B	1.36B	1.91B	1.54B
China Growth	45.71%	-2.84%	-29.21%	24.09%	-
Abroad	216.94M	216.40M	78.94M	79.94M	44.15M
Abroad Growth	0.25%	174.13%	-1.26%	81.08%	-
Total	2.14B	1.53B	1.43B	1.99B	1.59B
Total Growth	39.29%	6.90%	-28.09%	25.68%	-

Source: S&P Global Market Intelligence.